<unk>  is a serotonin (5-HT1B/1D) receptor agonist that is FDA approved for the {{{indicationType}}} of acute treatment of migraine with or without aura in adults.   Common adverse reactions include dizziness, headache, paresthesia, dry mouth, dyspepsia, fatigue, hot or cold sensation, chest pain, skeletal pain, and flushing.
Frovatriptan
Rizatriptan
Sumatriptan 
Eletriptan
Almotriptan
Naratriptan
Zolmitriptan 
Olopatadine 